Fundraising Fox
Stratosvir
Stevenage, GB · 2 known investors
Find your way into Stratosvir
Sign up to see every warm intro you have to Stratosvir
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stratosvir team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stratosvir develops engineered viral immunotherapy treatments for advanced cancers, including prostate cancer, using modified viruses to activate the body's immune system against tumors. The company targets patients with advanced solid tumors where current treatment options are limited.
Founders & leadership
Board
Investors · 2
How we know: the company's own site · the Companies House PSC register · Not right? Tell us
How we know: the company's own site · funding news · press coverage · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- STRATOSVIR LIMITED
- Company number
- 13099988
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 24 Dec 2020
- Registered office
- 46-54 High Street, Ingatestone, CM4 9DW
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 24 Dec 2025 · next due 7 Jan 2027
Current officers · 4
- Laura Margaret Fletcher — director, appointed 10 May 2021
- Priya Mande — director, appointed 6 Nov 2023
- Juan Antonio Postigo — director, appointed 10 May 2021
- Christopher Graeme Ullman — director, appointed 24 Dec 2020
Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Stratosvir do?
- Stratosvir develops engineered viral immunotherapy treatments for advanced cancers, including prostate cancer, using modified viruses to activate the body's immune system against tumors. The company targets patients with advanced solid tumors where current treatment options are limited.
- Who are Stratosvir's investors?
- Stratosvir's investors include Deep Science Ventures, O2h Ventures.
- Where is Stratosvir headquartered?
- Stratosvir is headquartered in Stevenage, GB.